The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. - Wikidata - wikimedia - TriplyDB

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.

http://www.wikidata.org/entity/Q43059527

about

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Update on pancreatic neuroendocrine tumors.Detection of insulinoma using (68)Gallium-DOTATATE PET/CT: a case report.Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.86Y based PET radiopharmaceuticals: radiochemistry and biological applications Somatostatin receptor based imaging and radionuclide therapy.Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.Paragangliomas and paraganglioma syndromes.Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice.Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate Pancreatic Neuroendocrine Tumors: an Update.New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.).Difficult diagnosis and localization of focal nesidioblastosis: clinical implications of (68)Gallium-DOTA-D-Phe(1)-Tyr(3)-octreotide PET scanning.The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective Prospective of ⁶⁸Ga-radiopharmaceutical development.Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68.Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors The molecular pathogenesis and management of bronchial carcinoids.Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis.Zollinger-Ellison syndrome: recent advances and controversies.Neuroendocrine tumours: the role of imaging for diagnosis and therapy.Role of (18) F-FDOPA PET/CT imaging in endocrinology.The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.(68) Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting.Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc.Review article: the investigation and management of rectal neuroendocrine tumours.

P2860

Q24603675-416ADA46-C15E-460F-8F7C-E1F270F69539 Q26992201-C61EAA7B-E7D9-40EE-9126-81B2E94EF3F6 Q26996521-5D0E1948-6E59-424D-8EA6-7CC881EA1F1F Q27027682-99ADB279-D0EE-4DD4-8C0A-FF61C7613C36 Q28066013-5983F761-FEE3-40BC-B0C7-618D15F00596 Q28078610-E8C70A1B-B0B2-495E-B1F7-39DEF9337B19 Q28260008-A7EBC235-AAB7-4B05-8075-428AE771D029 Q34157385-1E0B6ABC-5970-4925-B02E-9AAC20CA42A9 Q34453043-2000ABAC-44BB-4DA1-9FF9-05EBCEA1397C Q34573596-32FECA1C-9DE7-4A95-84AA-B87EC2811882 Q34987701-75D6B169-9BEA-412C-8D37-0BE88FFCE3F8 Q35250409-94155542-AB0F-43FE-B8E8-981E9C0E6F16 Q35296661-70F14313-9058-4D32-B6A8-98FC83AA8D7C Q35371197-A888A992-1D2F-4777-9045-406DD2E8FB05 Q35894770-F10520DC-153E-4526-8333-97FF98CDE522 Q35922755-16D27D2B-9751-4356-8111-237A4BD4A367 Q35926265-3172C69D-2561-4096-A290-D4A8B7D19CE6 Q36084862-DFF9E69D-4A56-494A-A302-8A25ECEE375C Q36143456-2D6C6279-B425-4CF3-984B-1311A735354D Q36400062-A8C7C7EE-408F-437D-A9D7-1860DA5F0B8F Q36595679-33CBB672-D52A-4C19-888D-C0648622C10F Q37088933-ABD2930A-331B-4A1C-90B0-D071D13EA1D5 Q37137705-F2CD2F56-DCD2-4BA6-A37F-D3BDA41411AA Q37347947-AAEB1F34-9A63-4B39-B20D-4C3C04972566 Q37435222-8684DB60-5138-410C-9FAF-141DD5770C56 Q37644820-1C15BDF3-961E-4BFF-88F2-6A451AAA3E9D Q37648915-5E845C96-86B7-4891-9207-97247E1C28A6 Q37717372-0C047C97-C1A8-420B-ADFC-8856F4C06D08 Q37833109-E979DFA7-8CB1-4FED-8E9B-D146763ECEFF Q37986605-EF23E4DB-DE41-4A23-AF24-D81B9A437A44 Q37990397-4894358E-6824-46C3-B5B5-64D6E4F93D09 Q38123057-2BF692B7-0807-46FF-8F5D-DA5D265A62F4 Q38127505-76C0FF5F-E4F3-4DE6-AE94-B7FD4E180A73 Q38150165-0A5348CF-4A07-4F36-B242-3892CFF71811 Q38169928-3304D82E-5A76-4061-8179-46CAC6EB46B0 Q38233342-890160EF-F14E-4A10-8C6B-FC3993FFBFBA Q38241845-F1F575E4-D13D-4B43-8E89-597BFD8237E3 Q38676211-D05F11CD-5548-475D-90C4-324DD2A894C7 Q38729041-A2A17B09-3692-48F5-BFFB-354C74D28547 Q38865549-D27166E5-F033-4F18-A945-A98C4E717B24

P2860

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.

http://www.wikidata.org/entity/Q43059527

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

The role of 68Ga-DOTATATE PET ...... -DTPA-octreotide scintigraphy.

@en

The role of 68Ga-DOTATATE PET ...... -DTPA-octreotide scintigraphy.

@nl

type

label

The role of 68Ga-DOTATATE PET ...... -DTPA-octreotide scintigraphy.

@en

The role of 68Ga-DOTATATE PET ...... -DTPA-octreotide scintigraphy.

@nl

prefLabel

The role of 68Ga-DOTATATE PET ...... -DTPA-octreotide scintigraphy.

@en

The role of 68Ga-DOTATATE PET ...... -DTPA-octreotide scintigraphy.

@nl

P1433

Q43059527-DF553828-26F6-4010-8D23-A94728ADD495

P1476

Q43059527-83F5D58B-5981-427D-8A76-1E2141D9E033

P2093

Q43059527-1425E94A-0190-47EE-885B-C9D061CD2233

Q43059527-20D41BA5-F4D9-4E62-BCEF-57EEDFBB2932

Q43059527-2AC7D451-F268-4D38-A572-3BFDFEEA28E7

Q43059527-9242D2E3-A066-4669-8B10-DAF27AE3230E

Q43059527-B437FF69-5289-4A57-B964-17D44F3504E9

Q43059527-BF5282CD-F923-4D64-8989-9F48529478CE

P304

Q43059527-C7AA61B9-3B92-4ECB-BF71-2407B0CCCC77

P31

Q43059527-848A5130-97F9-4FCF-919D-08F6048D274E

P356

Q43059527-B0698D57-BDB1-4AEC-B16D-5F41BB84ADA4

P407

Q43059527-4200A9F4-4615-47AC-BB69-1D3B13040DEF

P433

Q43059527-576CF1D5-CAD2-442F-AC64-4A83EDCD1196

P478

Q43059527-69FFCCFF-9C3D-420E-82CF-048E3CC010E2

P577

Q43059527-D4D3E7D1-F0AC-461B-AFB7-21F36BC53108

P5875

Q43059527-6BE06F46-81AA-4575-89DA-01ED812A954D

P698

Q43059527-EE2BDDD5-BC09-4A4F-AEA8-0EE53E05801C

P356

JNUMED.109.066134

P1433

The Journal of Nuclear Medicine

P1476

The role of 68Ga-DOTATATE PET ...... -DTPA-octreotide scintigraphy.

@en

P2093

Anne Marie Quigley

http://www.w3.org/2001/XMLSchema#string

Irfan Kayani

http://www.w3.org/2001/XMLSchema#string

Jade Soh

http://www.w3.org/2001/XMLSchema#string

Jamshed Bomanji

http://www.w3.org/2001/XMLSchema#string

Martyn E Caplin

http://www.w3.org/2001/XMLSchema#string

Rajaventhan Srirajaskanthan

http://www.w3.org/2001/XMLSchema#string

P304

875-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.109.066134

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44613229

http://www.w3.org/2001/XMLSchema#string

P698

20484441

http://www.w3.org/2001/XMLSchema#string